The table below shows Summit Therapeutics Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
$0.00
$0.00
$705.00K
$1.81M
$860.00K
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
-
-
$59.47M
$52.00M
$85.35M
$53.27M
SG&A
SMMT annual revenue (10-K history)
Summit Therapeutics Inc. reported annual revenue of $0.00 for fiscal year 2024. Over the 8 fiscal years shown, annual revenue declined from $16.10M (FY 2018) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.
